🇺🇸 FDA
Patent

US 12358909

Capsazepine analogs for the treatment of cancer and other proliferative diseases

granted A61KA61K31/155A61K31/165

Quick answer

US patent 12358909 (Capsazepine analogs for the treatment of cancer and other proliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/155, A61K31/165, A61K31/17, A61K31/4035